VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 234,049,687
- Share change
- +2,082,092
- Total reported value
- $65,932,675,845
- Put/Call ratio
- 96%
- Price per share
- $281.79
- Number of holders
- 1,093
- Value change
- +$619,489,758
- Number of buys
- 476
- Number of sells
- 512
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.4%
|
23,916,254
|
$6,241,425,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8%
|
20,473,471
|
$5,342,963,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
5.2%
|
13,181,713
|
$3,440,031,000 | — | 31 Mar 2022 | |
| Capital World Investors |
13F
|
Company |
5%
|
12,666,130
|
$3,305,417,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
12,052,763
|
$3,145,410,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
4.1%
|
10,555,041
|
$2,754,549,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
8,053,710
|
$2,101,776,000 | — | 31 Mar 2022 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.5%
|
6,389,023
|
$1,667,343,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
5,304,697
|
$1,384,367,000 | — | 31 Mar 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2%
|
5,152,752
|
$1,344,714,000 | — | 31 Mar 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.9%
|
4,947,363
|
$1,290,137,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
4,812,669
|
$1,255,961,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
4,330,231
|
$1,127,130,000 | — | 31 Mar 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.4%
|
3,515,153
|
$917,351,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
3,139,337
|
$819,272,778 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
3,118,547
|
$813,846,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,889,953
|
$754,191,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
1%
|
2,624,748
|
$684,980,486 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
2,148,626
|
$560,726,000 | — | 31 Mar 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.81%
|
2,057,129
|
$536,849,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
2,002,865
|
$522,687,000 | — | 31 Mar 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.75%
|
1,902,551
|
$496,509,000 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.71%
|
1,805,599
|
$471,208,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.67%
|
1,707,368
|
$445,572,000 | — | 31 Mar 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.64%
|
1,640,031
|
$427,999,000 | — | 31 Mar 2022 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.69%
|
1,769,276
|
$417,339,000 | — | 31 Mar 2022 | |
| Bellevue Group AG |
13F
|
Company |
0.58%
|
1,480,253
|
$386,302,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.52%
|
1,327,466
|
$346,429,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
1,243,707
|
$324,570,000 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.48%
|
1,210,357
|
$315,867,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.49%
|
1,257,734
|
$314,761,000 | — | 31 Mar 2022 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.46%
|
1,174,608
|
$306,537,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.44%
|
1,124,756
|
$293,521,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.43%
|
1,101,175
|
$287,374,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
1,100,875
|
$287,295,000 | — | 31 Mar 2022 | |
| APG Asset Management N.V. |
13F
|
Company |
0.45%
|
1,156,889
|
$271,346,000 | — | 31 Mar 2022 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.38%
|
978,372
|
$255,326,000 | — | 31 Mar 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.38%
|
975,384
|
$254,546,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.37%
|
953,174
|
$248,718,000 | — | 31 Mar 2022 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.36%
|
912,697
|
$238,187,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.36%
|
907,666
|
$236,874,000 | — | 31 Mar 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.35%
|
897,841
|
$234,308,000 | — | 31 Mar 2022 | |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. |
13F
|
Company |
0.34%
|
868,617
|
$226,683,000 | — | 31 Mar 2022 | |
| Impax Asset Management Group plc |
13F
|
Company |
0.34%
|
860,672
|
$224,610,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.33%
|
851,082
|
$222,106,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.33%
|
840,095
|
$219,239,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
825,849
|
$215,521,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.32%
|
808,554
|
$211,008,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.31%
|
793,290
|
$207,025,000 | — | 31 Mar 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
748,855
|
$195,428,000 | — | 31 Mar 2022 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2022
As of 30 Jun 2022,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,093 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
234,049,687 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital World Investors, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, and AMERIPRISE FINANCIAL INC.
This page lists
1,094
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
1,050
Q2 2022 holders
1,093
Holder diff
43
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.